These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10697547

  • 1. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.
    Streffer JR, Schuster M, Pohl U, Belka C, Dichgans J, Bamberg M, Weller M.
    Anticancer Res; 1999; 19(6B):5265-9. PubMed ID: 10697547
    [Abstract] [Full Text] [Related]

  • 2. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
    Glaser T, Wagenknecht B, Groscurth P, Krammer PH, Weller M.
    Oncogene; 1999 Sep 09; 18(36):5044-53. PubMed ID: 10490841
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S, Weller M.
    J Pharmacol Exp Ther; 1998 Sep 09; 286(3):1374-82. PubMed ID: 9732400
    [Abstract] [Full Text] [Related]

  • 4. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA, Khan T, Koul D, Lang FF, Conrad CA, Yung WK, Liu TJ.
    Int J Oncol; 2004 Feb 09; 24(2):409-17. PubMed ID: 14719118
    [Abstract] [Full Text] [Related]

  • 5. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 09; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 6. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
    Wagenknecht B, Schulz JB, Gulbins E, Weller M.
    Cell Death Differ; 1998 Oct 09; 5(10):894-900. PubMed ID: 10203695
    [Abstract] [Full Text] [Related]

  • 7. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M.
    Oncogene; 2001 Jul 12; 20(31):4128-37. PubMed ID: 11464279
    [Abstract] [Full Text] [Related]

  • 8. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B, Roth W, Gulbins E, Wolburg H, Weller M.
    Cell Death Differ; 2001 Jun 12; 8(6):595-602. PubMed ID: 11536010
    [Abstract] [Full Text] [Related]

  • 9. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 12; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia sensitizes human malignant glioma cells towards CD95L-induced cell death.
    Steinbach JP, Wolburg H, Klumpp A, Weller M.
    J Neurochem; 2005 Mar 12; 92(6):1340-9. PubMed ID: 15748153
    [Abstract] [Full Text] [Related]

  • 11. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U, Kügler S, Wolburg H, Wick W, Rascher G, Schulz JB, Conseiller E, Bähr M, Weller M.
    Cancer Res; 2001 Aug 01; 61(15):5833-42. PubMed ID: 11479223
    [Abstract] [Full Text] [Related]

  • 12. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma.
    Wagenknecht B, Glaser T, Naumann U, Kügler S, Isenmann S, Bähr M, Korneluk R, Liston P, Weller M.
    Cell Death Differ; 1999 Apr 01; 6(4):370-6. PubMed ID: 10381630
    [Abstract] [Full Text] [Related]

  • 13. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
    Glaser T, Wagenknecht B, Weller M.
    Oncogene; 2001 Aug 09; 20(35):4757-67. PubMed ID: 11521188
    [Abstract] [Full Text] [Related]

  • 14. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F, Knobbe CB, Frank B, Wolburg H, Weller M.
    Oncol Rep; 2008 Apr 09; 19(4):1061-6. PubMed ID: 18357397
    [Abstract] [Full Text] [Related]

  • 15. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U, Wagenknecht B, Naumann U, Weller M.
    Cell Physiol Biochem; 1999 Apr 09; 9(1):29-37. PubMed ID: 10352342
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer.
    Rieger J, Ständer M, Löschmann PA, Heneka M, Dichgans J, Klockgether T, Weller M.
    Oncogene; 1998 Nov 05; 17(18):2323-32. PubMed ID: 9811463
    [Abstract] [Full Text] [Related]

  • 17. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
    Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, Orfanos CE, Geilen CC.
    Oncogene; 2003 Dec 11; 22(57):9131-41. PubMed ID: 14668794
    [Abstract] [Full Text] [Related]

  • 18. Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis.
    Steinbach JP, Eisenmann C, Klumpp A, Weller M.
    Biochem Biophys Res Commun; 2004 Aug 27; 321(3):524-30. PubMed ID: 15358139
    [Abstract] [Full Text] [Related]

  • 19. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
    Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M.
    Oncogene; 1999 Jul 08; 18(27):3936-43. PubMed ID: 10435616
    [Abstract] [Full Text] [Related]

  • 20. Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells.
    Yount GL, Levine KS, Kuriyama H, Haas-Kogan DA, Israel MA.
    Cancer Res; 1999 Mar 15; 59(6):1362-5. PubMed ID: 10096571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.